Ye Wei
Impact in
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 51
- Colorectal Cancer Surgical Treatments 27
- Colorectal Cancer Treatments and Studies 13
- Colorectal Cancer Screening and Detection 5
- Hepatology 26
- Hepatocellular Carcinoma Treatment and Prognosis 24
- Co-authors
- Li Ren (53 shared papers)Dexiang Zhu (51 shared papers)Jianmin Xu (41 shared papers)Lechi Ye (13 shared papers)Guodong He (24 shared papers)Jianmin Xu (29 shared papers)Wenju Chang (36 shared papers)Meiling Ji (21 shared papers)
- Journals
- PLoS ONE (8 papers)Cancer Management and Research (6 papers)Annals of Oncology (5 papers)The American Journal of Surgery (5 papers)Oncotarget (4 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Ye Wei
201 papers receiving 5.4k citations
Ye Wei's Hit Papers
Peers
Comparison fields: 5 of 151
- Cancer Research 1.2k
- Hepatology 491
- Oncology 1.7k
- Orthodontics 89
- Pathology and Forensic Medicine 366
Countries citing papers authored by Ye Wei
This map shows the geographic impact of Ye Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Wei more than expected).
Fields of papers citing papers by Ye Wei
This network shows the impact of papers produced by Ye Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Wei. The network helps show where Ye Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Ye Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 211 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): short-term outcomes of a multicentre randomised controlled trial Hit paper breakdown → | 2022 | 328 |
| 2 | 2013 | 323 | |
| 3 | 2011 | 188 | |
| 4 | 2004 | 187 | |
| 5 | 2017 | 140 | |
| 6 | 2009 | 138 | |
| 7 | 2019 | 116 | |
| 8 | 2003 | 116 | |
| 9 | 2019 | 114 | |
| 10 | 2012 | 110 | |
| 11 | 2001 | 108 | |
| 12 | 2005 | 92 | |
| 13 | 2020 | 91 | |
| 14 | 2018 | 91 | |
| 15 | 2008 | 85 | |
| 16 | 2012 | 82 | |
| 17 | 2002 | 75 | |
| 18 | 2005 | 72 | |
| 19 | 2012 | 70 | |
| 20 | 2020 | 68 |
About Ye Wei
Ye Wei is a scholar working on Oncology, Hepatology, Cancer Research, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 211 papers that have together received 5.5k indexed citations. Recurring topics across this work include Colorectal Cancer Surgical Treatments (27 papers), Hepatocellular Carcinoma Treatment and Prognosis (24 papers), Colorectal Cancer Treatments and Studies (13 papers), Cancer-related molecular mechanisms research (13 papers), Gastric Cancer Management and Outcomes (13 papers), Microbial Natural Products and Biosynthesis (9 papers), Breast Cancer Treatment Studies (7 papers) and Colorectal Cancer Screening and Detection (5 papers). The work is most often cited by research in Cancer Research (1.2k citations), Hepatology (491 citations), Oncology (1.7k citations), Orthodontics (89 citations) and Pathology and Forensic Medicine (366 citations). Ye Wei has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Li Ren, Dexiang Zhu, Jianmin Xu, Lechi Ye, Guodong He, Jianmin Xu, Wenju Chang, Meiling Ji, Qing‐Hai Ye and Qi Lin. Their work appears in journals such as PLoS ONE, Cancer Management and Research, Annals of Oncology, The American Journal of Surgery and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.